Events

Adenosine deaminase–deficient severe combined immunodeficiency (ADA-SCID) is a rare, life-threatening inborn error of the immune system characterized by profound T-, B-, and NK-cell dysfunction and multiorgan complications beginning in early infancy. Integration of newborn screening using T-cell receptor excision circles,...

C3 glomerulopathy (C3G) is a rare, complement-mediated kidney disease characterized by abnormal activation of the complement system, resulting in excessive deposition of the complement protein C3 in the glomeruli and subsequent inflammation and injury. To address unmet needs and education...

Release Date: December 22, 2025 Expiration Date: December 22, 2026 Activity Overview This Collaborating Across the Continuum® video-based program features 2 experts using a case-based approach to explore how mental health screening can be integrated into dermatology practice, recognizing the...

In this online, on-demand educational video, Steven J Greene, MD, and Anu Lala, MD, will discuss the intersection of CKD and heart failure and the role diabetes plays in these diseases, current guidelines for CKD testing in at-risk patients, and...

This educational program for hematologists delivers a practical, evidence-based update on the management of pain and other common complications in patients with sickle cell disease (SCD). The curriculum emphasizes both acute and chronic pain across the lifespan, integrating current guideline...

This online, on-demand virtual symposium brings together renowned experts in treating major depressive disorder (MDD). In this educational program, these experts discuss managing patients with MDD by reviewing patient scenarios, reflecting on how to handle challenging cases, and integrating relevant...

In generalized myasthenia gravis (gMG), pathogenic antibodies activate the terminal complement cascade at the neuromuscular junction, leading to membrane attack complex–mediated damage of the postsynaptic membrane. Complement C5 inhibition directly blocks this mechanism, addressing a central driver of disease rather...

The neonatal Fc receptor (FcRn) preserves IgG by preventing lysosomal degradation, thereby extending IgG half-life. Inhibition of FcRn enhances the clearance of pathogenic IgG autoantibodies, resulting in rapid and reversible reductions in circulating AChR and MuSK antibodies without causing broad...

Release Date: December 23, 2025 Expiration Date: December 23, 2026 Activity Overview The neonatal Fc receptor (FcRn) rescues immunoglobulin G (IgG) from lysosomal degradation, prolonging IgG half-life. FcRn blockade accelerates degradation of pathogenic IgG autoantibodies, leading to rapid, reversible reductions in circulating...

Sickle cell disease (SCD) has entered a transformative era marked by significant progress in disease-modifying therapy (DMT) and curative strategies. This educational program brings together leading SCD experts to explore the latest evidence, real-world insights, and clinical considerations shaping modern...